Optimising best practice in prescribing statins

Clinical update & case study

Speakers: ,

In association with HEART UK

PCSK9 inhibitors provide an effective way of lowering LDL cholesterol in high risk patients. This however comes at a cost to the NHS. Accurate information should be obtained from the outset so as to ensure a seamless application process for funding. Rigorous clinical monitoring ensures the safe use of a relatively new drug. Education of lipid clinic staff is essential in ensuring that this process becomes an integral part of the lipid clinic. The development of this service has highlighted various challenges however this had led to increased knowledge of using the drug.

View Mr Darren Harvey’s presentation »

Download Mr Darren Harvey’s Key Messages Slide »

« Back to Interactive Programme